For: | Sheen IS, Jeng KS, Tsai YC. Is the expression of γ-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol 2003; 9(3): 468-473 [PMID: 12632499 DOI: 10.3748/wjg.v9.i3.468] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i3/468.htm |
Number | Citing Articles |
1 |
Subramaniam Mohana Devi, Vellingiri Balachandar, Meyyazhagan Arun, Shanmugam Suresh Kumar, Balasubramanian Balamurali Krishnan, Keshavarao Sasikala. Analysis of Genetic Damage and Gene Polymorphism in Hepatocellular Carcinoma (HCC) Patients in a South Indian Population. Digestive Diseases and Sciences 2013; 58(3): 759 doi: 10.1007/s10620-012-2409-8
|
2 |
Yone-Han Mah, Ching-Sheng Hsu, Chen-Hua Liu, Chun-Jen Liu, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan. Hepatology International 2011; 5(3): 814 doi: 10.1007/s12072-010-9248-5
|
3 |
Pei-Pei Song, Ju-Feng Xia, Yoshinori Inagaki, Kiyoshi Hasegawa, Yoshihiro Sakamoto, Norihiro Kokudo, Wei Tang. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 262-274 doi: 10.3748/wjg.v22.i1.262
|
4 |
Ming Li, Pengcheng Sun, Kaikai Dong, Ye Xin, Aslee TaiLulu, Qinyu Li, Jing Sun, Min Peng, Ping Shi. Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells. Archives of Pharmacal Research 2021; 44(2): 194 doi: 10.1007/s12272-021-01311-z
|
5 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
6 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
7 |
Peipei Song, Wei Tang, Norihiro Kokudo. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_4-1
|
8 |
Jufeng Xia, Peipei Song, Zhipeng Sun, Tatsuo Sawakami, Mingku Jia, Zhigang Wang. Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma. Drug Discoveries & Therapeutics 2016; 10(4): 181 doi: 10.5582/ddt.2016.01052
|
9 |
Peipei Song, Wei Tang, Norihiro Kokudo. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 901 doi: 10.1007/978-94-007-7675-3_4
|
10 |
Fabio Grizzi, Barbara Franceschini, Cody Hamrick, Eldo E Frezza, Everardo Cobos, Maurizio Chiriva-Internati. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-3
|
11 |
Ranjit Chauhan, Nivedita Lahiri. Tissue- and Serum-Associated Biomarkers of Hepatocellular Carcinoma. Biomarkers in Cancer 2016; : BIC.S34413 doi: 10.4137/BIC.S34413
|
12 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
13 |
Tara Behne, M. Sitki Copur. Biomarkers for Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/859076
|
14 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|